“…Of those 15, only nine studies reported that more than 70% of patients received primary EBRT [ 26 , 29 , 33 , 38 , 40 , 41 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 ]. Across all studies, ADT was initiated as adjuvant therapy in four studies [ 28 , 42 , 54 , 56 ], neoadjuvant therapy in seven studies [ 30 , 33 , 36 , 37 , 41 , 44 , 50 ], and both adjuvant and neoadjuvant in two studies [ 29 , 40 ]. Nineteen studies reported on ADT with no further details [ 26 , 31 , 32 , 34 , 35 , 39 , 43 , 45 , 46 , 48 , 49 , 51 , 52 , 53 , 55 , 57 , 58 , 59 ], and three studies did not report on the use of ADT [ 27 , 38…”